Topoisomerases are enzymes that reduce DNA supercoiling by introducing cuts in DNA strands. TopoGEN recognises the unique details of topoisomerase drug discovery and provides innovative reagents and kits for topoisomerase research and mechanism-based drug development in cancer.
Kits are available to assay for topoisomerases (I, II, IV and gyrase) and Tdp1, to measure topo/DNA interactions in vivo and to identify new topoisomerase drugs. The company also offers a complete line of DNA substrates topo inhibitors, antibodies and kit replenishment reagents.
Phone: 02 9698 2022
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
Azure Biosystems Ao Microplate Reader
The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...
